Physician profile
David Joung
NPI 1972864544
$741.71
in general payments reported to CMS, 2019-2025
12 companies · $127 in 2025
The $127 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $153 · 2020: $25.82 · 2021: $17.76 · 2022: $50.17 · 2023: $274 · 2024: $94.71 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.02 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $222.37 | 2022-2025 | Bexsero, Pediarix, Penmenvy |
| Pfizer INC. | $72.63 | 2020-2023 | |
| Sanofi Pasteur INC. | $72.22 | 2022-2024 | |
| Neos Therapeutics, LP | $67.10 | 2019 | |
| Cumberland Pharmaceuticals, INC. | $62.34 | 2023 | Kristalose |
| Cranial Technologies, INC | $56.51 | 2023-2025 | Doc Band |
| Kaleo, INC. | $50.46 | 2019-2024 | Auvi-Q |
| Verrica Pharmaceuticals INC. | $48.97 | 2025 | Ycanth |
| Sanofi-Aventis U.S. LLC | $33.50 | 2025 | |
| Prugen, INC. Pharmaceuticals | $24.18 | 2019 | |
| Alexion Pharmaceuticals, INC. | $19.39 | 2019 | |
| Merck Sharp & Dohme LLC | $12.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Joung listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.